Nuclear Medicine and Biology
Volume 36, Issue 1 , Pages 11-16 , January 2009

Dopamine transporter binding in rat striatum: a comparison of [O-methyl-11C]β-CFT and [N-methyl-11C]β-CFT

  • Karmen K. Yoder

      Affiliations

    • Department of Radiology, Indiana University School of Medicine, L3-208, Indianapolis, IN 46202, USA
    • ,
  • Gary D. Hutchins

      Affiliations

    • Department of Radiology, Indiana University School of Medicine, L3-208, Indianapolis, IN 46202, USA
    • ,
  • Bruce H. Mock

      Affiliations

    • Department of Radiology, Indiana University School of Medicine, L3-208, Indianapolis, IN 46202, USA
    • ,
  • Xiangshu Fei

      Affiliations

    • Department of Radiology, Indiana University School of Medicine, L3-208, Indianapolis, IN 46202, USA
    • ,
  • Wendy L. Winkle

      Affiliations

    • Department of Radiology, Indiana University School of Medicine, L3-208, Indianapolis, IN 46202, USA
    • ,
  • Bruce D. Gitter

      Affiliations

    • Lilly Center for Anatomical and Molecular Imaging, Integrative Biology Division, Lilly Research Laboratories, Greenfield, IN 46140, USA
    • ,
  • Paul R. Territo

      Affiliations

    • Lilly Center for Anatomical and Molecular Imaging, Integrative Biology Division, Lilly Research Laboratories, Greenfield, IN 46140, USA
    • ,
  • Qi-Huang Zheng

      Affiliations

    • Department of Radiology, Indiana University School of Medicine, L3-208, Indianapolis, IN 46202, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 317 278 4671; fax: +1 317 278 9711.

Received 11 June 2008 ,Revised 13 August 2008 ,Accepted 15 October 2008.

References 

  1. Boja JW, Patel A, Carroll FI, Rahman MA, Philip A, Lewin AH, et al. [125I]RTI-55: a potent ligand for dopamine transporters. Eur J Pharmacol. 1991;194:133–134
  2. Clarke RL, Daum SJ, Gambino AJ, Aceto MD, Pear J, Levitt M, et al. Compounds affecting the central nervous system. 4. 3β-Phenyltropane-2-carboxylic esters and analogs. J Med Chem. 1973;16:1260–1267
  3. Cham R, Studenski SA, Perera S, Bohnen NI. Striatal dopaminergic denervation and gait in healthy adults. Exp Brain Res. 2008;185:391–398
  4. Bohnen NI, Kuwabara H, Constantine GM, Mathis CA, Moore RY. Grooved pegboard test as a biomarker of nigrostriatal denervation in Parkinson's disease. Neurosci Lett. 2007;424:185–189
  5. Pellegrino D, Cicchetti F, Wang X, Zhu A, Yu M, Saint-Pierre M, et al. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats. J Nucl Med. 2007;48:1147–1153
  6. Bohnen NI, Gedela S, Kuwabara H, Constantine GM, Mathis CA, Studenski SA, et al. Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease. J Neurol. 2007;254:84–90
  7. Rinne JO, Hublin C, Nagren K, Helenius H, Partinen M. Unchanged striatal dopamine transporter availability in narcolepsy: a PET study with [11C]-CFT. Acta Neurol Scand. 2004;109:52–55
  8. Nurmi E, Bergman J, Eskola O, Solin O, Vahlberg T, Sonninen P, et al. Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET. Synapse. 2003;48:109–115
  9. Brownell AL, Livni E, Galpern W, Isacson O. In vivo PET imaging in rat of dopamine terminals reveals functional neural transplants. Ann Neurol. 1998;43:387–390
  10. Morris ED, Babich JW, Alpert NM, Bonab AA, Livni E, Weise S, et al. Quantification of dopamine transporter density in monkeys by dynamic PET imaging of multiple injections of 11C-CFT. Synapse. 1996;24:262–272
  11. Kawamura K, Oda K, Ishiwata K. Age-related changes of the [11C]CFT binding to the striatal dopamine transporters in the Fischer 344 rats: a PET study. Ann Nucl Med. 2003;17:249–253
  12. Rinne JO, Laihinen A, Nagren K, Rutottinen H, Rutosalainen U, Rinne UK. PET examination of the monoamine transporter with [11C]β-CIT and [11C]β-CFT in early Parkinson's disease. Synapse. 1995;21:97–103
  13. Gitter BD, Horn JW, Brown JM, Territo PR, Winkle W, Yoder KK, et al. Histological validation of dopamine transporter PET images in the rat 6-OHDA lesion model of Parkinson's disease. J Histotechnol. 2007;30:123–129
  14. Brashear A, Mulholland GK, Zheng QH, Farlow MR, Siemers ER, Hutchins GD. PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia-parkinsonism (RDP). Mov Disord. 1999;14:132–137
  15. Yoder KK, Hutchins GD, Morris ED, Brashear A, Wang C, Shekhar A. Dopamine transporter density in schizophrenic subjects with and without tardive dyskinesia. Schizophr Res. 2004;71:371–375
  16. Zheng QH, Mulholland GK. Improved synthesis of β-CIT and [11C]β-CIT labeled at nitrogen or oxygen positions. Nucl Med Biol. 1996;23:981–986
  17. Lundkvist C, Halldin C, Swahn CG, Ginovart N, Farde L. Different brain radioactivity curves in a PET study with [11C]β-CIT labelled in two different positions. Nucl Med Biol. 1999;26:343–350
  18. Mock BH, Mulholland GK, Vavrek MJ. Convenient gas phase bromination of [11C]methane and production of [11C]methyl triflate. Nucl Med Biol. 1999;26:467–471
  19. Meltzer PC, Liang AY, Brownell AL, Elmaleh DR, Madras BK. Substituted 3-phenyltropane analogs of cocaine: synthesis, inhibition of binding at cocaine recognition sites, and positron emission tomography imaging. J Med Chem. 1993;36:855–862
  20. Zheng QH, Mulholland GK. Isomerization study of aryltropane analogs of cocaine. Syn Commun. 2000;30:333–340
  21. Carroll IV, Abraham P, Lewin AH, Parham KA, Boja JW, Kuhar MJ. Isopropyl and phenyl esters of 3β-(4-substituted phenyl)tropan-2β-carboxylic acids. Potent and selective compounds for the dopamine transporter. J Med Chem. 1992;35:2497–2500
  22. Mock BH, Zheng QH, DeGrado TR. A multi-purpose 11C-radio-synthesis system. J Label Compd Radiopharm. 2005;48:S225
  23. Mock BH, Glick-Wilson BE, Zheng QH, DeGrado TR. Automated measurement of specific activity of radiolabeled ligands during synthesis. J Label Compd Radiopharm. 2005;48:S224
  24. Rouze NC, Hutchins GD. Design and characterization of IndyPET-II: a high-resolution, high-sensitivity dedicated research scanner. IEEE Trans Nucl Sci. 2003;50:1491–1497
  25. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27:1533–1539
  26. Muller L, Halldin C, Farde L, Karlsson P, Hall H, Swahn CG, et al. Millius. [11C]β-CIT, a cocaine analogue. Preparation, autoradiography and preliminary PET investigations. Nucl Med Biol. 1993;20:249–255
  27. Dannals RF, Neumeyer JL, Milius RA, Ravert HT, Wilson AA, Wagner HN. Synthesis of a radiotracer for studying dopamine uptake sites in vivo using PET: 2β-carbomethoxy-3β-(4-fluorophenyl)-[N-11C-methyl]tropane ([11C]CFT or[11C]WIN 35,428). J Label Compd Radiopharm. 1993;33:147–152
  28. Zheng QH, Mock BH. Purification of carbon-11 PET radiotracers from unlabeled precursors by preparative HPLC and SPE. Biomed Chromatogr. 2005;19:671–676
  29. Kung MP, Kung HF. Mass effect of injected dose in small rodent imaging by SPECT and PET. Nucl Med Biol. 2005;32:673–678
  30. Hume SP, Brown DJ, Ashworth S, Hirani E, Luthra SK, Lammertsma AA. In vivo saturation kinetics of two dopamine transporter probes measured using a small animal positron emission tomography scanner. J Neurosci Methods. 1997;76:45–51

PII: S0969-8051(08)00231-X

doi: 10.1016/j.nucmedbio.2008.10.007

Nuclear Medicine and Biology
Volume 36, Issue 1 , Pages 11-16 , January 2009

Article Tools

* Image Usage & Resolution